Case Study on Modafinil: Usage, Availability, and Impact in the USA Introduction Modafinil, a wakefulness-promoting agent, has gained significant attention in the United States for its potential to enhance cognitive function and combat sleep disorders such as narcolepsy and obstructive sleep apnea. Originally developed in the 1970s and approved by the FDA in 1998, modafinil has transcended its initial medical applications and emerged as a popular cognitive enhancer among healthy individuals. This case study explores the online availability, usage patterns, and societal impact of modafinil in the USA. Background Modafinil is classified as a Schedule IV controlled substance in the United States, which means it is recognized as having a lower potential for abuse compared to other stimulants. Despite its legal status, the drug has become increasingly accessible through online pharmacies, raising questions about regulation, safety, and ethical implications. Online Availability The rise of the internet has transformed how medications are purchased. Many individuals seeking modafinil for cognitive enhancement or productivity boosts turn to online pharmacies, often bypassing traditional healthcare channels. A simple search for "buy modafinil online" yields numerous websites, some of which operate legally while others do not. Legal Online Pharmacies Legal online pharmacies require a prescription from a licensed healthcare provider. These pharmacies are often certified and comply with regulations set forth by the National Association of Boards of Pharmacy (NABP). Patients can obtain modafinil by consulting a physician, who can evaluate their needs and determine if the medication is appropriate. Illicit Online Pharmacies Conversely, illicit online pharmacies often operate without proper oversight, selling modafinil without a prescription.